We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$53.3B
AUM Growth
+$1.63B
(+3.2%)
Cap. Flow
-$179M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
17.17%
Holding
3,102
New
155
Increased
2,027
Reduced
775
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$67.7M |
| 2 |
Corteva
CTVA
|
+$33.4M |
| 3 |
TCF
TCF Financial Corporation Common Stock
TCF
|
+$19.3M |
| 4 |
Spotify
SPOT
|
+$15.3M |
| 5 |
Amcor
AMCR
|
+$15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$62.6M |
| 2 |
Apple
AAPL
|
+$51.5M |
| 3 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$29.7M |
| 4 |
NXP Semiconductors
NXPI
|
+$28.9M |
| 5 |
Microsoft
MSFT
|
+$23.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.25% |
| 2 | Financials | 15.55% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Industrials | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Agilysys
AGYS
$3.09B
| $1.09M | ﹤0.01% |
50,931
+1,211
| +2% | +$25.1K |
|
|
AMAG
2027
DELISTED
AMAG Pharmaceuticals
AMAG
| $1.09M | ﹤0.01% |
109,393
+5,527
| +5% | +$59.6K |
|
2028
German American Bancorp
GABC
$1.92B
| $1.09M | ﹤0.01% |
36,218
+2,595
| +8% | +$76.3K |
|
2029
MacroGenics
MGNX
$243M
| $1.09M | ﹤0.01% |
64,276
+13,266
| +26% | +$228K |
|
2030
Modine Manufacturing
MOD
$10.4B
| $1.09M | ﹤0.01% |
76,005
+3,166
| +4% | +$45.3K |
|
|
HTBK
2031
DELISTED
Heritage Commerce
HTBK
| $1.09M | ﹤0.01% |
88,702
+13,825
| +18% | +$170K |
|
2032
PDF Solutions
PDFS
$2.01B
| $1.09M | ﹤0.01% |
82,753
+2,506
| +3% | +$32.1K |
|
2033
Center Bancorp
CNOB
$1.68B
| $1.08M | ﹤0.01% |
47,706
+3,116
| +7% | +$67.2K |
|
2034
Intellia Therapeutics
NTLA
$1.5B
| $1.08M | ﹤0.01% |
66,040
+12,193
| +23% | +$192K |
|
2035
Digi International
DGII
$2.65B
| $1.08M | ﹤0.01% |
84,957
+2,883
| +4% | +$35K |
|
|
CNSL
2036
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $1.08M | ﹤0.01% |
218,511
+7,988
| +4% | +$50.9K |
|
2037
iShares Russell 2000 ETF
IWM
$81.5B
| $1.08M | ﹤0.01% |
6,920
-21,472
| -76% | -$3.31M |
|
|
AUD
2038
DELISTED
Audacy, Inc.
AUD
| $1.07M | ﹤0.01% |
185,352
+506
| +0.3% | +$3.11K |
|
|
EVRI
2039
DELISTED
Everi Holdings
EVRI
| $1.07M | ﹤0.01% |
89,715
+3,528
| +4% | +$38.3K |
|
|
LDL
2040
DELISTED
Lydall, Inc.
LDL
| $1.07M | ﹤0.01% |
52,817
+2,399
| +5% | +$52.2K |
|
|
UBNK
2041
DELISTED
United Financial Bancorp, Inc.
UBNK
| $1.06M | ﹤0.01% |
75,022
+1,401
| +2% | +$19.2K |
|
2042
Madrigal Pharmaceuticals
MDGL
$11.1B
| $1.06M | ﹤0.01% |
10,140
+1,030
| +11% | +$110K |
|
2043
Liberty Energy
LBRT
$3.1B
| $1.06M | ﹤0.01% |
65,632
+9,611
| +17% | +$147K |
|
|
STFC
2044
DELISTED
State Auto Financial Corp
STFC
| $1.06M | ﹤0.01% |
30,340
+828
| +3% | +$28.1K |
|
2045
Great Southern Bancorp
GSBC
$886M
| $1.06M | ﹤0.01% |
17,722
+381
| +2% | +$21.7K |
|
|
TBRG
2046
DELISTED
TruBridge
TBRG
| $1.06M | ﹤0.01% |
38,169
+3,529
| +10% | +$98.6K |
|
|
CTLP
2047
DELISTED
Cantaloupe
CTLP
| $1.06M | ﹤0.01% |
142,548
+2,562
| +2% | +$15.9K |
|
2048
Upwork
UPWK
$1.18B
| $1.06M | ﹤0.01% |
65,847
+49,052
| +292% | +$845K |
|
|
DPLO
2049
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $1.06M | ﹤0.01% |
173,813
+13,863
| +9% | +$73.7K |
|
2050
Century Aluminum
CENX
$4.47B
| $1.06M | ﹤0.01% |
153,044
+5,937
| +4% | +$44.1K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2019 Portfolio in Review
As of Q2 2019, RhumbLine Advisers held 3,102 positions worth $53.3B, up 3.2% from $51.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
RhumbLine Advisers's Q2 2019 filing shows 155 new, 2,027 increased, 775 reduced and 131 closed positions. Its largest new stake was Dow Inc: 1,282,896 shares worth $63.3M. The largest sale was DuPont de Nemours, an estimated $62.6M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q2 2019 buy was Dow Inc: 1,282,896 shares worth $63.3M.
- RhumbLine Advisers added most to TCF Financial Corporation Common Stock in Q2 2019, an estimated $19.3M increase.
- RhumbLine Advisers's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $62.6M.
- RhumbLine Advisers fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $29.7M.
- RhumbLine Advisers's ten largest holdings make up 17% of its $53.3B portfolio in Q2 2019.
- RhumbLine Advisers opened 155 new positions and closed 131 in Q2 2019.
- RhumbLine Advisers's portfolio value rose 3.2% quarter-over-quarter to $53.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.